Skip to main content

Table 1 Study visit schedule

From: A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial

 

Baseline

SPC within 3 weeks

4 weeks

8 weeks

12 weeks

16 weeks

20 weeks

24 weeks

Monthly SPC until Death/EOT

24 weeks after death

Intervention

          

Patient

QLQC-30, LC13, EQ-5D, GHQ-12

X

   

X

  

X

  

SPC review

 

X

X

X

X

X

X

X

X

 

Telephone interview (QLQC-30, LC13)

  

X

X

 

X

X

   

Carer

GHQ-12, SF-36, FAMCARE-2

X

   

X

  

X

 

X

Control

          

Patient

QLQC-30, LC13, EQ-5D, GHQ-12

X

   

X

  

X

  

Telephone interview (QLQC-30, LC13)

  

X

X

 

X

X

   

Carer

GHQ-12, SF-36, FAMCARE-2

X

   

X

  

X

 

X

  1. EOT = end of trial;EQ-5D = EuroQol-5D;FAMCARE-2 = family satisfaction with advanced cancer care 2; GHQ-12 = General Health Questionnaire-12; LC13 = lung cancer supplement;,QLQ-C30 = Quality of Life Questionnaire Core 30;SF-36 = Short Form 36;SPC = Specialist Palliative Care.
Back to article page

Trials

ISSN: 1745-6215